X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.bayer.com/media/en-us/bluerock-therapeutics-phase-i-clinical-trial-for-parkinsons-disease-continues-to-show-positive-trends-at-18-months/
https://www.prnewswire.com/news-releases/bluerock-therapeutics-exercises-exclusive-option-to-license-ipsc-cell-therapy-candidate-opct-001-for-treating-primary-photoreceptor-diseases-from-fujifilm-cellular-dynamics-and-opsis-therapeutics-302041694.html
https://www.bayer.com/en/us/news-stories/investigational-cellular-therapy-bemdaneprocel
https://www.prnewswire.com/news-releases/bluerocks-phase-i-study-with-bemdaneprocel-in-patients-with-parkinsons-disease-meets-primary-endpoint-301910863.html
https://www.fiercebiotech.com/biotech/bayer-bought-bluerock-cuts-12-workforce-across-three-sites-pipeline-contracts
https://www.prnewswire.com/news-releases/bluerock-therapeutics-and-bitbio-announce-collaboration-and-option-agreement-for-the-discovery-and-manufacture-of-regulatory-t-cell-treg-based-therapies-301892322.html
https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-phase-i-trial-results-parkinsons-cell-therapy-positive-2023-06-28/
https://www.fiercebiotech.com/cro/bayer-subsidiary-bluerock-taps-rune-labs-parkinsons-study-software
https://www.globenewswire.com/news-release/2022/08/24/2503641/0/en/BioCardia-Enters-Agreement-with-BlueRock-Therapeutics-to-Provide-Enabling-Catheter-Biotherapeutic-Delivery-Product-Candidates-for-BlueRock-s-Cell-Therapy-to-Treat-Heart-Failure.html
https://www.europeanpharmaceuticalreview.com/news/172171/new-berlin-site-cell-therapy-bluerock-therapeutics/
Market Place
Share 
